
    
      Parents of newborns will be invited to test if their newborns are affected with SMA. The
      routine newborn screening dried blood spots sample will be used to test if missing 2 copies
      of SMN1 gene. If positive of screening test, further confirmation tests including physical
      examination and other methology for SMN1 gene copies quantification will be provided. Genetic
      counseling and treatment option will be provided, too.
    
  